Professor of Radiology

Email: pcaravan@partners.org

Further Information

---

Recent Publications

• Blandino AA, Caravan P, Ricciardi R, Bordeianou LG, Kunitake H, Goldstone RN, Drage MG, Zhang ML, Ananthakrishnan AN, Catalano OA. Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn's disease. Eur J Nucl Med Mol Imaging. 2026 Feb 17.
• Ning Y, Zhou IY, Schaub JR, Rotile NJ, Boice A, Ay I, Turner S, Caravan P. Multimodal Imaging Demonstrates Antifibrotic Effects of Targeting a v ß 6 /a v ß 1 Integrins in Biliary Fibrosis. Invest Radiol. 2026 Jan 01. 61(1):59-67
• Clavijo Jordan V, Sojoodi M, Moloudi F, Gonzalez Pagan P, Jin M, Pantazopoulos P, French E, Eissa I, Weigand-Whittier J, Rotile N, Tavallai M, Hallin J, Ramsay I, Gale EM, Barrett SC, El-Bardeesy N, Shroff S, Qadan M, Tanabe KK, Caravan P. Molecular MRI of Dysregulated Zinc Secretion Detects Pancreatic Ductal Adenocarcinoma and Response to KRASG12D Inhibitor Treatment. Cancer Res. 2025 Nov 14. 85(22):4541-4557
• Zhou IY, Zhang C, Sojoodi M, Rotile NJ, Lan Y, Barrett SC, Wang C, Schaefer CJ, Kossen K, Seiwert SD, Tanabe KK, Caravan P. 18F-FPP-RGD2 PET Imaging for Interrogating Target Engagement and Antifibrotic Activity of an Integrin Antagonist in a Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis. J Nucl Med. 2025 Nov 03. 66(11):1795-1802
• Herold A, Hajati A, Cao Y, Fialkowski KP, Ghosh S, Delaney F, Heidari P, Picchio M, Mapelli P, Chiti A, Anderson MA, Peña-Trujillo V, Kambadakone A, Blake MA, Shufflebeam S, Catana C, Caravan P, Weber M, Huang SY, Catalano OA. Per-Lesion Assessment of Individual MRI Sequences and 68Ga-DOTATATE PET in Neuroendocrine Liver Metastases. Invest Radiol. 2025 Oct 27.